Infinity Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals

INFI 0.0160

-4.8%

Sep 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (53)	8/1/2006 5:46:20 PM
From: Mike McFarland	Read Replies (1) of 210

There may be an inherent limit to the efficacy of direct Hsp90 inhibition, resulting from induction of the antiapoptotic chaperone Hsp70. Other mechanisms, such as HDAC inhibition, can also affect the Hsp90 chaperone, and a combination of direct Hsp90 inhibitors and HDAC inhibitors, or Hsp90 inhibitors in combination with standard chemotherapeutics and newer targeted agents, may provide the most productive way forward. Targeting Hsp90 for the treatment of cancer (Vernalis, Novartis authors) Current Opinion in Drug Discovery & Development 2006 9(4):483-495 thomson-pharma.com Infinity, Kosan, Conforma molecules mentioned, one to print and read a few times--I still have not found any Chiosis papers for free. Today was the record date for voting on the merger. There seems to be little interest in trading shares around/ either an "I'll play these cards" or the vote is already figured out anyway. google.com That paper is the third hit using google. Much of these papers goes over my head anyway...but I think it likely we are not going to see any surprise move upward to the valuation when INFI comes out. The only play is going to be to wait for them to build some value over time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next